KIFAP3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.938600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.201800E-01
Normal-vs-Stage2
7.035000E-01
Normal-vs-Stage3
5.974600E-01
Normal-vs-Stage4
7.691600E-01
Stage1-vs-Stage2
8.534200E-01
Stage1-vs-Stage3
6.186600E-01
Stage1-vs-Stage4
4.108200E-01
Stage2-vs-Stage3
3.867200E-01
Stage2-vs-Stage4
5.303400E-01
Stage3-vs-Stage4
3.848000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.882200E-01
Normal-vs-AfricanAmerican
5.465000E-01
Normal-vs-Asian
3.315600E-01
Caucasian-vs-AfricanAmerican
1.029590E-01
Caucasian-vs-Asian
1.392190E-01
AfricanAmerican-vs-Asian
1.515820E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.900200E-01
Normal-vs-Female
8.180600E-01
Male-vs-Female
8.902600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.993600E-01
Normal-vs-Age(41-60Yrs)
9.780600E-01
Normal-vs-Age(61-80Yrs)
7.243400E-01
Normal-vs-Age(81-100Yrs)
9.082400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.942800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.369200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.185400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.168390E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.002000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.802800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.699000E-01
Normal-vs-Daily Drinker
4.632000E-01
Normal-vs-Weekly Drinker
8.315400E-01
Normal-vs-Occasional Drinker
7.093000E-01
Normal-vs-Social Drinker
8.142800E-01
Non Drinker-vs-Daily Drinker
5.998000E-01
Non Drinker-vs-Weekly Drinker
5.714400E-01
Non Drinker-vs-Occasional Drinker
4.598100E-02
Non Drinker-vs-Social Drinker
6.669600E-01
Daily Drinker-vs-Weekly Drinker
3.629200E-01
Daily Drinker-vs-Occasional Drinker
2.978200E-02
Daily Drinker-vs-Social Drinker
4.442800E-01
Weekly Drinker-vs-Occasional Drinker
2.751400E-01
Weekly Drinker-vs-Social Drinker
9.335200E-01
Occasional Drinker-vs-Social Drinker
2.596200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.097200E-01
Normal-vs-Grade 2
5.816200E-01
Normal-vs-Grade 3
1.227220E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.559400E-01
Grade 1-vs-Grade 3
9.747600E-01
Grade 1-vs-Grade 4
2.097200E-01
Grade 2-vs-Grade 3
3.499200E-01
Grade 2-vs-Grade 4
5.816200E-01
Grade 3-vs-Grade 4
1.227220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.277400E-01
Normal-vs-NonDiabetic
8.495800E-01
Diabetic-vs-NonDiabetic
2.516400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.673200E-01
Normal-vs-NoPancreatitis
8.462600E-01
Pancreatitis-vs-NoPancreatitis
6.736800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.101000E-01
Normal-vs-N1
6.710800E-01
N0-vs-N1
1.040770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.963800E-01
Normal-vs-TP53-NonMutant
8.082400E-01
TP53-Mutant-vs-TP53-NonMutant
3.826400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
